Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Prime Medicine Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
PRME
Nasdaq
8731
https://primemedicine.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Prime Medicine Inc
Alphabet Bought Up Two Slumping Stocks
- May 12th, 2024 7:00 am
Is Prime Medicine (NASDAQ:PRME) In A Good Position To Invest In Growth?
- May 11th, 2024 1:02 pm
Prime Medicine Inc (PRME) Q1 2024 Earnings: Navigates Through Challenges with Strategic Developments
- May 10th, 2024 6:23 pm
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
- May 10th, 2024 12:00 pm
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
- May 8th, 2024 12:00 pm
What Makes Prime Medicine, Inc. (PRME) a New Buy Stock
- May 3rd, 2024 4:00 pm
Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
- May 1st, 2024 12:00 pm
Prime Medicine gets green light for trials of first-ever prime editing drug
- Apr 30th, 2024 10:01 am
Prime gets FDA green light to begin first trial test of ‘prime editing’
- Apr 29th, 2024 11:35 am
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
- Apr 29th, 2024 11:00 am
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
- Apr 23rd, 2024 12:00 pm
2 Magnificent Growth Stocks With Room to Run
- Mar 27th, 2024 12:45 pm
Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging
- Mar 14th, 2024 6:44 pm
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
- Mar 1st, 2024 7:00 pm
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
- Mar 1st, 2024 1:00 pm
14 Stocks With Heavy Insider Buying In 2024
- Feb 29th, 2024 8:02 am
Prime Medicine to Participate in Upcoming Investor Conferences
- Feb 28th, 2024 1:00 pm
With 34% ownership, Prime Medicine, Inc. (NASDAQ:PRME) has piqued the interest of institutional investors
- Feb 25th, 2024 2:20 pm
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- Feb 20th, 2024 9:01 pm
Prime Medicine Announces Pricing of Upsized Public Offering
- Feb 15th, 2024 4:50 am
Scroll